Syngenta Group’s planned $10 billion (CHF9.3 billion) initial public offering (IPO) in China has been temporarily suspended due to missing financial information from the agrichemical giant, the Shanghai Stock Exchange said on Monday.
State-owned ChemChina bought the Basel-based Swiss agriscience group Syngenta for $44 billion in 2017. ChemChina’s application to list on Shanghai’s STAR Market was accepted at the start of July and was widely expected to be the world’s largest flotation this year.
The STAR market suspended 57 applications on September 30, citing a lack of updated financial information. Under bourse rules, applicants must provide additional information if financial materials in applications are outdated.
“The application review has been temporarily paused”,
ChemChina is also considering a secondary listing for Syngenta that could take place less than a year after its Shanghai debut, with exchanges in Zurich, London and New York among the options being examined, sources told Reuters.
Foreign investment control system
The takeover of Syngenta in 2017 and airline catering business Gategroup by Chinese companies in 2016 sparked a reaction by the Swiss authorities and new rules.
In the future the takeover of Swiss companies by foreign state-owned or state-linked funds is to be better regulated. The government has laid down the broad outlines of a foreign investment control system. Concerned about the international trend of company takeovers, parliamentarians adopted a motion in March 2020 to protect the Swiss economy.
Popular Stories
More
Foreign affairs
European nations snub Swiss-made weapons over Ukraine restrictions
Switzerland will deliver rubble removal equipment to Ukraine
This content was published on
Thirty rubble removal machines and thirty fire-fighting pumps: this is the equipment that Switzerland will be delivering to the Ukraine in the next few days. The total value of these goods is 5.6 million Swiss francs.
A third of Swiss residents plan to change health insurers
This content was published on
After the announced sharp increase in premiums for 2025, about one in three people would be considering changing health insurance companies.
Swiss-led study unravels tree growth and longevity
This content was published on
Trees reach old age using different strategies. This is shown by a Swiss-led research team with over 100 scientists from all over the world in a new study, for which they analyzed trees that live to be over three thousand years old.
This content was published on
The man who injured three children on Tuesday has been detained in pre-trial custody after a request by the public prosecutor’s office.
This content was published on
Over 60% of Swiss voters have thrown out a pair of initiatives aiming to ban the use of synthetic pesticides in the country.
Swiss-based firms spend tens of millions lobbying Brussels
This content was published on
The chemicals industry invested the most money (up to €8.4 million) in presenting their arguments to top EU officials on proposed regulations, legislation and other matters. The Swiss-based Dow Europe spent up to €2.75 million while pharmaceutical company Novartis weighed in with upwards of €2.5 million and crop protection firm Syngenta spent some €1.75 million.…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.